A CAR-T CELL THERAPY TARGETING GLYPICAN-3 POSITIVE HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Wang, B. [1 ]
Ngoh, E. [1 ]
Soh, M. K. [1 ]
Yeap, Y. [1 ]
Huang, H. [1 ]
Tan, H. C. [1 ]
Hu, Y. [1 ]
Wang, C. I. [1 ]
机构：
[1] ASTAR, Singapore Immunol Network, Human Monoclonal Antibodies Platform, Singapore, Singapore
来源：
HUMAN GENE THERAPY | 2018年 / 29卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
ICLE8-0009
引用
收藏
页码：A16 / A16
页数：1
相关论文
共 50 条
  • [31] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Li Wang
    Min Yao
    Liu-Hong Pan
    Qi Qian
    Deng-Fu Yao
    [J]. Hepatobiliary & Pancreatic Diseases International, 2015, 14 (04) : 361 - 366
  • [32] Glypican-3 and Alphafetoprotein as Diagnostic Tests for Hepatocellular Carcinoma
    Jorge Filmus
    Mariana Capurro
    [J]. Molecular Diagnosis, 2004, 8 (4) : 207 - 212
  • [33] DEVELOPMENT AND VALIDATION OF AN SCFV SPECIFIC FOR HUMAN GLYPICAN-3 FOR THERAPY OF HEPATOCELLULAR CARCINOMA
    Li, Yonghai
    Zhao, Aizhi
    Li, Hong
    Adeyemo, Oluwasayo
    Elkin, Daniel
    Scholler, Nathalie
    Kaplan, David E.
    [J]. HEPATOLOGY, 2009, 50 (04) : 1135A - 1135A
  • [34] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Wang, Li
    Yao, Min
    Pan, Liu-Hong
    Qian, Qi
    Yao, Deng-Fu
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (04) : 361 - 366
  • [35] NOVEL PEPTIDE BINDER TO GLYPICAN-3 FOR TARGETED RADIOPHARMACEUTICAL THERAPY OF HEPATOCELLULAR CARCINOMA
    Song, Ken
    [J]. INTERNAL MEDICINE JOURNAL, 2023, 53 : 10 - 10
  • [36] Novel peptide binder to Glypican-3 for targeted radiopharmaceutical therapy of hepatocellular carcinoma
    Li, Gary
    Lin, Fanching
    Clift, Renee
    Ehara, Takeru
    Yanagida, Hayato
    Horton, Steven
    Salvador, Katrina
    Richardson, Samantha
    Guest, Matt
    Noncovich, Alain
    Bhat, Abhijit
    Han, Guangzhou
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] T-CELL RE-DIRECTION AGAINST GLYPICAN-3 FOR IMMUNOTHERAPY OF HEPATOCELLULAR CARCINOMA (HCC)
    Dargel, C.
    Bassani-Sternberg, M.
    Wilde, S.
    Dossinger, G.
    Kerbs, K.
    Schiemann, M.
    Schendel, D.
    Busch, D. H.
    Mann, M.
    Protzer, U.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S40 - S40
  • [38] Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy
    Chen, I-Pei
    Ariizumi, Shun-ichi
    Nakano, Masayuki
    Yamamoto, Masakazu
    [J]. JOURNAL OF GASTROENTEROLOGY, 2014, 49 (01) : 117 - 125
  • [39] Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma
    Yorita, Kenji
    Takahashi, Nobuyasu
    Takai, Hirotake
    Kato, Atsuhiko
    Suzuki, Masami
    Ishiguro, Takahiro
    Ohtomo, Toshihiko
    Nagaike, Koki
    Kondo, Kazuhiro
    Chijiiwa, Kazuo
    Kataoka, Hiroaki
    [J]. LIVER INTERNATIONAL, 2011, 31 (01) : 120 - 131
  • [40] Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy
    I-Pei Chen
    Shun-ichi Ariizumi
    Masayuki Nakano
    Masakazu Yamamoto
    [J]. Journal of Gastroenterology, 2014, 49 : 117 - 125
12345